Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.CHINA INNOVATION INVESTMENT LIMITED (incorporated in the Cayman Islands with limited liability)(Stock Code: 1217) 2012 INTERIM RESULTS ANNOUNCEMENT
The board (the “Board”) of directors (the “Directors”) of China Innovation Investment Limited (the “Company”) are pleased to announce the unaudited interim results of the Company for the six months ended 30 June 2012 with comparative figures for the corresponding period of 2011 as follows:
CONDENSED STATEMENT OF COMPREHENSIVE INCOME For the six months ended 30 June 2012 Six months ended 30 June HK$’000 (Unaudited)
(Loss)/gain on disposal of financial assets at fair value through profit or loss
Gain on disposal of investment properties
Fair value change of financial assets at fair value through profit or loss
(Loss)/profit before taxation (Loss)/profit for the period and attributable to owners of the Company (Loss)/earnings per share (in HK cents)
Total comprehensive income for the period and attributable to owners of the Company
CONDENSED STATEMENT OF FINANCIAL POSITION At 30 June 2012 HK$’000 (Unaudited) NON-CURRENT ASSETS Property, plant and equipment
Deposit for acquisition of available-for-sale investments
CURRENT ASSETS Financial assets at fair value through profit
Deposits, prepayment and other receivables
CURRENT LIABILITIES Accruals and other payables NET CURRENT ASSETS NET ASSETS CAPITAL AND RESERVES Equity attributable to owners of the Company Share TOTAL EQUITY CONDENSED STATEMENT OF CHANGES IN EQUITY For the six months ended 30 June 2012 option Accumulated At 1 January 2012 (20,177) Total comprehensive income for the period At 30 June 2012 (24,907)
Total comprehensive income for the period
Under the Companies Law of the Cayman Islands, the share premium of the Company is available for paying distributions or dividends to the shareholders subject to the provisions of the Articles of Association of the Company and a statutory solvency test. Under the Articles of Association of the Company, dividend may be declared or payable out of the profits and reserves of the Company lawfully available for distribution with the sanction of an ordinary resolution. Dividend may also be declared out of share premium account of the Company. As at 30 June 2012, the Company’s reserve available for distribution amounted to approximately HK$288,775,000 (30 June 2011: approximately HK$294,619,000).
The share option reserve comprises the fair value of unexercised share options granted to directors, employees and business advisors of the Company recognised in accordance with HKFRS 2.
investment revaluation reserve arises on the revaluation of available-for-sale financial assets.
When a revalued financial asset is sold, the portion of the reserve related to that financial asset, and is effectively realised, is recognised in profit or loss. CONDENSED STATEMENT OF CASH FLOWS For the six months ended 30 June 2012 Six months ended 30 June HK$’000 (Unaudited)
Net cash (used in)/generated by investing activities
Net cash generated by financing activities
NET (DECREASE)/INCREASE IN CASH AND CASH EQUIVALENTS (13,269)
Cash and cash equivalents at the beginning of the period
CASH AND CASH EQUIVALENTS AT THE END OF THE PERIOD ANALYSIS OF BALANCES OF CASH AND CASH EQUIVALENTS Cash and bank balances
Non-pledged time deposits with original maturity of less than three months when acquires
NOTES TO THE CONDENSED FINANCIAL STATEMENTS 1 Corporate information
The Company is incorporated in the Cayman Islands as an exempted company with limited liability under the Companies Law (2001 Second Revision) of the Cayman Islands and the Company’s shares are listed on The Stock Exchange of Hong Kong Limited (the “Stock Exchange”). The address of its registered office and principal place of business of the Company are disclosed in the “Corporate Information” section of the interim report.
The Company is an investment holding company. Its principal investment objective is to achieve medium-term capital appreciation by investing in listed and unlisted companies mainly in Hong Kong and the People’s Republic of China (the “PRC”). Basis of preparation The unaudited condensed financial statements have been prepared in accordance with the applicable disclosure requirements of Appendix 16 to the Listing Rules and with Hong Kong Accounting Standard (“HKAS”) 34 “Interim Financial Reporting” issued by the Hong Kong Institute of Certified Public Accountants (“HKICPA”).
The unaudited condensed financial statements do not include all the information and disclosures required in the annual financial statements, and should be read in conjunction with the Company’s annual financial statements for the year ended 31 December 2011. Summary of significant accounting policies The Company has adopted all the new and revised HKFRSs issued by the HKICPA that are relevant to its operations and effective for its accounting period beginning on 1 January 2012. HKFRSs comprise Hong Kong Financial Reporting Standards (“HKFRS”); Hong Kong Accounting Standards (“HKAS”); and Interpretations. The adoption of these new and revised HKFRSs did not result in significant changes to the Company’s accounting policies, presentation of the Company’s financial statements and amounts reported for the current period and prior years.
The Company has not applied the new HKFRSs that have been issued but are not yet effective. The Company has already commenced an assessment of the impact of these new HKFRSs but is not yet in a position to state whether these new HKFRSs would have a material impact on its results of operations and financial position. (Loss)/profit before taxation Six months ended 30 June HK$’000 (Unaudited)
The Company’s (loss)/profit before taxation is arrived at after charging:
Depreciation of property, plant and equipment
Employee benefit expense, including Directors’ remuneration — wages, salaries and others
— contribution to retirement benefits scheme
Operating lease charge for land and buildings
Loss on disposal of property, plant and equipment
Income tax expense No provision for Hong Kong profits tax has been made for the six months ended 30 June 2012 and 30 June 2011 as the Company did not generate any assessable profits. (Loss)/earnings per share The calculation of basic (loss)/earnings per share is based on the loss attributable to owners of the Company of approximately HK$4,730,000 (2011: profit of approximately HK$425,000) and the weighted average number of 6,979,385,753 (2011: 6,979,385,753) shares in issue during the period.
The computation of the diluted (loss)/earnings per share does not assume the exercise of the Company’s share options as the exercise would decrease the loss per share of both current and prior periods. 6 Available-for-sale investments HK$’000 Cash and cash equivalents HK$’000 (Unaudited)
Cash held in securities account of securities companies
Authorised: 15,000,000,000 ordinary shares of HK$0.01 each
Issued and fully paid: 6,979,385,753 ordinary shares of HK$0.01 each
Under the share option scheme (the “Scheme”) approved by the sole shareholder of the Company on 18 July 2002, the board of directors of the Company may, at their discretion, invite any full- time employee, director (including non-executive director and independent non-executive director), any part time employee with weekly working hours of 15 hours or above of the Company or its subsidiaries, any advisor or consultant to the Company or to any of its subsidiaries and adviser, consultant, agent or business affiliates who has contributed to the Company to subscribe for shares in the Company.
Pursuant to the Scheme, the overall limit on the number of shares which may be issued upon exercise of all options granted and yet to be exercised under the Scheme and other share options schemes of the Company must not exceed 30% of the shares in issue from time to time. The total number of shares issued and to be issued upon exercise of the options granted and to be granted to each eligible participant (including both exercised and outstanding options) in any 12-month period must not exceed 1% of the shares in issue at any time. Any further grant of options in excess of this limit is subject to the shareholders’ approval of the Company in a general meeting with such participant(s) and his associate(s) abstaining from voting.
The offer of a grant of share options may be accepted within 7 days from the date of the offer, upon payment of a consideration of HK$1.00 in total by the grantee. The exercise period of the share options granted is determinable by the directors, and commences on a specified date and ends on a date which is not later than 10 years from the date of the offer of the share options.
The exercise price of the share options is determinable by the directors of the Company, but may not be less than the highest of (a) the closing price of the shares as stated in the daily quotations sheets issued by the Stock Exchange on the date of grant; (b) the average closing price of the shares as stated in the daily quotations sheets issued by the Stock Exchange for the 5 business days immediately preceding the date of grant; and (c) the nominal value of a share on the date of grant.
Movements of the options granted under the Scheme during the six months ended 30 June 2012 and outstanding at 30 June 2012 were as follows:
Number of share options Price per Outstanding Outstanding share to be Exercised 1 January exercise Option period the period the period the period of options
As at 30 June 2012, the number of shares issuable under the Scheme represented approximately 0.21% (31 December 2011: approximately 3.99%) of the Company’s shares in issue as at that date. Net assets value per share The calculation of net asset per share is based on the net asset value of the Company as at 30 June 2012 of approximately HK$387,387,000 (31 December 2011: approximately HK$392,117,000) and 6,979,385,753 (31 December 2011: 6,979,385,753) ordinary share in issue at the date. Connected and related party transactions Six months ended 30 June HK$’000 (Unaudited)
Investment management fee paid to China Everbright Securities (HK) Limited (note a)
Rental expense paid to New Era Group (China) Limited (note b)
Rental deposit paid to New Era Group (China) Limited (note b)
The Company has entered into an investment management agreement with China Everbright Securities (HK) Limited (“CES”) for a period of three years commencing from 1 June 2003 in consideration of a payment of a fee calculated at 0.25% per annum of the net asset value of the Company as at the last dealing date on the Stock Exchange in each calendar month or such other valuation date as considered appropriate by the Board and payable on a monthly basis on a business date immediately after each valuation date. The agreement is renewed automatically for a period of three years upon expiry unless a written notice of termination by either party for not less than 3 months is served. In addition, CES is entitled to a bonus fee equivalent to 10% of the audited profit before tax of each financial year of the Company payable on the business date immediately after the publication of the Company’s final audited result for the year. CES is regarded as a connected person of the Company for the purpose of the Listing Rules. Mr. Chan Cheong Yee, a director of the Company, is the authorised representative of CES. On 23 October 2007, a revision on the service charge to HK$300,000 per annum by monthly payment of HK$25,000 and the annual bonus was maximised to HK$1,000,000 with effect from 1 January 2008 was proposed and accepted. On 28 February 2012, a revision on the service charge to HK$960,000 per annum by monthly payment of HK$80,000 and the annual bonus was cancelled with effect from 20 May 2012 was proposed and accepted.
The Company has entered into a tenancy agreement with New Era Group (China) Limited (“NEG”), a company of which Mr. Xiang Xin is also a director, (the “Tenancy Agreement”) for the occupancy of an office premises for a 3 years term commenced from 1 July 2008 with rent-free period from 1 July 2008 to 31 August 2008. On 1 January 2011, the Company agreed to renew and extend the terms of the Tenancy Agreement with NEG for a term of three years commencing from 1 July 2011 and expiring on 30 June 2014. Pursuant to the Tenancy Agreement, the Company shall pay a deposit of HK$160,000 and a monthly rental of HK$80,000 to NEG. The deposit was included in deposit and prepayment in the statement of financial position. 12 Commitment (a) Operating
At the balance sheet date, the Company had commitments for future minimum lease payments under non-cancellable operating leases in respect of rented premises, which fall due as follows:
Operating lease payments represent rental payable by the Company for its office premises. Leases are negotiated for the term of three years. (b) Capital commitment HK$’000 (Unaudited)
Commitment for the acquisition of available-for-sale investments
13 Contingent liabilities
The Company did not have any material contingent liabilities at the balance sheet date.
14 Interim dividends
The directors do not recommend the payment of an interim dividend for the six months ended 30 June 2012 (2011: Nil). Financial review For the six months ended 30 June 2012, the Company recorded a total revenue of approximately HK$111,000 (2011: approximately HK$2,648,000). This decrease in revenue was mainly attributable to the decrease in the interest income.
The loss for the six months ended 30 June 2012 was approximately HK$4,730,000 while the profit for the corresponding period of 2011 was approximately HK$425,000. Business review The Company is an investment holding company and the Company’s shares were listed on The Main Board of The Stock Exchange of Hong Kong Limited on 28 August 2002 pursuant to Chapter 21 of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited.
During the six months ended 30 June 2011, there was interest income in the amount of approximately HK$1,193,000 and HK$1,250,000 earned from convertible bonds bought from Takenaka Industry Company Limited and interest-bearing debt instrument from Morgan Strategic Limited respectively. There was no similar convertible bond and debt instrument being made during the six months ended 30 June 2012. As a result, there was a sharp decrease in interest income by approximately 90.1% during the six months ended 30 June 2012 when compared to the corresponding period in 2011.
During the six months ended 30 June 2011, there was disposal gain in the amount of approximately HK$3,392,000 earned from investment properties. There was no similar disposal of investment properties during the six months ended 30 June 2012.
As a result of the weak global economy and volatile financial market, the Company did not have any significant investments on the principle of the cautious financial management and solid investment pace during the six months ended 30 June 2011.
As at 30 June 2012, the Company held investments in four unlisted companies namely Topsun Creation Limited, Aesthetic Vision Limited, United Crown Century Company Limited and Blue Angel (H.K.) Limited, which amounting to total cost and carrying values of approximately HK$317,774,000 and HK$313,274,000 respectively. Prospect The Company is one of the few investment companies in Hong Kong focusing investment in dual usage of military and civil sectors. We invest in listed and non-listed civil and military joint ventures with high quality to strive for medium-term gains from capital appreciation in the course of securitization of corporate assets invested, and apply the same as our key operation strategy and income source.
Leveraging on our experience and well-connected network in the Mainland market over years, the Company recently invested in military and civil dual-used charge storage batteries, new models of lighting products, eco-equipment materials and energy-saving media terminals respectively through its investment. With energy conservation as our development goal, our investments have achieved breakthroughs in realising the four new industries of “New Energy”, “New Light”, “New Materials” and “New Media”, military and civil dual-application in real projects. Investment Portfolios As at 30 June 2012, the Company hold the following investments:
The Company held 2,710 “B” non-voting shares in Topsun Creation Limited (“Topsun”), representing 67.75% interest in the issued share capital of Topsun. Topsun is incorporated in Hong Kong and principally engaged in investment holding. As at 30 June 2012, Topsun directly held 100% interest in (transliterated Topsun Creation (China) Limited, “Topsun China”, registered capital is RMB100 million and total investment is RMB200 million) which was incorporated in PRC. Topsun China focuses on the development and marketing of lead-acid batteries, and new energy storage batteries as the main product, the product is characterized by high capacity, fully sealed and maintenance-free. As the performance of lithium batteries are recognized, and PRC is determined to promote electric vehicles, so PRC obtains a great market prospect, Topsun China identified the lithium iron phosphate as the core product of the new energy storage batteries. On 8 May 2012, Topsun China and
(transliterated Jiangsu Felie Li-ion Battery Manufacture Co.,
Limited) entered into a framework agreement related to establish a joint venture company
Energy Technology Company Limited) (“Joint Venture”). According to the agreement, the registered capital of the Joint Venture is RMB100 million and total investment of the Joint Venture is RMB200 million, Topsun China holds 51% share, the Joint Venture will carry out R & D and production of lithium iron phosphate cathode material. According to the negotiation, the Joint Venture also plans the development of production and operation of downstream lithium iron phosphate lithium battery and lithium battery electric space vehicles.
The Company held 8,500 “B” non-voting shares in Aesthetic Vision Limited (“Aesthetic”), representing 85% interest in the issued share capital of Aesthetic. Aesthetic is incorporated in Hong Kong and principally engaged in investment holding. The principal assets of Aesthetic include its wholly-owned subsidiary
(transliterated Aesthetic Vision (China) Limited, “Aesthetic China”, registered
capital is RMB100 million and total investment is RMB200 million) which is incorporated in PRC of which its major product is LED lighting. Aesthetic possesses LED ergonomics technology with features including LED illuminant, appropriate light flux, free colour temperature, healthy spectrum and compliance to ergonomics. Its products are widely used in military production as well as civic purposes. On 28 June 2012, Aesthetic China and shareholders of
Shen Yi Network Technology Co. Limited, “Nanjing Shen Yi”) entered into framework agreement related to raise capital and increase shares. According to the agreement, Nanjing Shen Yi will raise the capital to RMB50 million, Aesthetic China holds 51% of shares. In addition, Nanjing Shen Yi purchase 50 acres of land from another company in Nanjing in Jiangsu Province to conduct capacity expansion.
(iii) The Company held 12,644 “B” non-voting shares in United Crown Century Company
Limited (“United Crown”), representing 52.68% interest in the issued share capital of United Crown. United Crown is incorporated in Hong Kong and principally engaged in investment holding. The principal assets of United Crown was indirectly hold 100% interest in
(transliterated United Crown Future (China)
Company Limited, “United China”, registered capital is RMB100 million and total investment is RMB200 million) which is incorporated in PRC of which is engaging in the research and development of energy-saving eco-wall. On 6 June 2012, United China and shareholders of
Fortune New Energy Co. Limited) (“Yangzhou Green Fortune”) entered into framework agreement related to raise capital and expand shares. According to the agreement, United China will invest about RMB50 million and will obtain 51% of share of Yangzhou Green Fortune. The registered capital of Yangzhou Green Fortune is US$5.6 million. Yangzhou Green Fortune is engaging in R & D and production of three-in-one new materials and energy-saving building components.
(iv) The Company held 48,500 “B” non-voting shares in Blue Angel (H.K.) Limited (“Blue
Angel”), representing 62.99% interest in the issued share capital of Blue Angel. Blue Angel is incorporated in Hong Kong and principally engaged in investment holding. The subsidiary company
Limited, “Blue China”, registered capital is HK$130 million and total investment is HK$230 million) is wholly-owned by Blue Angel which is incorporated in PRC of which mainly engages in producing and assembly of solar products with the use of solar energy and LED technologies, so as to develop a four new and completed industry chain and provide a one-stop production setting with synergy effect. On 9 May 2012, Blue China and
(transliterated Shen Zhen Mai Ji Ke Optoelectronics
Limited) entered into cooperative agreement. Both parties agreed to form a joint venture (“Joint Venture”). According to the agreement, the register capital of Joint Venture is RMB100 million and total investment of Joint Venture is RMB200 million. Blue China holds 51% of shares, Joint Venture will conduct R & D and production of TFT-LCD model and the designed annual capacity is 12 million pieces, the annual output value is RMB1.2 billion. Joint Venture will purchase a land in Jiangyan of Jiangsu Province to conduct production (54.9 acres has been implemented in first stage, 23 acres in second stage). The Joint Venture will also plan R & D and the development of production to the downstream solar flat panel displays and other energy saving media terminal.
Being dedicated to outline a four new and completed industry chain conservation, the Company is actively seeking for more investment opportunities in new technologies like solar energy and LED, in order to build a greener low-carbon living.
Looking forward, the Company will continue to explore the investment opportunities to achieve medium-term capital appreciation. Liquidity and financial resources and gearing As at 30 June 2012, the Company had cash and cash equivalents of approximately HK$84,640,000. All the cash and cash equivalents were mainly placed as short term deposits in Hong Kong dollars with banks and securities companies in Hong Kong.
For the period under review, the Company financed its operations with its own available funding and did not have any banking facilities. In this regard, the Company had a net cash position and its gearing ratio was zero (net debt to shareholders’ funds) as at 30 June 2012. Taking into consideration the existing financial resources of the Company, it is anticipated that the Company should have adequate financial resources to meet its ongoing operating and development requirements. Capital structure Details in the changes of the capital structure of the Company during the six months ended 30 June 2012 are set out in note 8 to the condensed financial statements. The capital of the Company comprises only ordinary shares as at 30 June 2012. Foreign currency fluctuation The Company mainly operates its business transaction in Hong Kong dollars and thus is not exposed to foreign currency risk. No hedging or other alternatives have been implemented. Charge on Company asset and contingent liabilities As at 30 June 2012, the Company has not pledge its assets and the Company did not have any significant contingent liabilities. Employee information As at 30 June 2012, the Company had 8 (2011: 11) employees. Interim dividend To maintain the capital for operation and potential investment opportunities, the Board does not recommend the payment of an interim dividend for the six months ended 30 June 2012. Purchase, Sale or Redemption of the Company’s Listed Securities During the six months ended 30 June 2012, the Company had not purchased, sold or redeemed any of its listed securities. Corporate Governance Code on Corporate Governance Practices The Company had complied with the Code on Corporate Governance Practice (“Code”) as set out in Appendix 14 to the Listing Rules during the six months ended 30 June 2012, save for deviation from Code A.2.1 and A.4.1.
Mr. Xiang Xin is the Chairman of the Board and the Chief Executive Officer of the Company. Such practice deviates from code provision A.2.1 of the Code on Corporate Governance Practices contained in Appendix 14 of the Listing Rules, which requires that the roles of Chairman and Chief Executive Officer should be separated and should not be performed by the same individual. After evaluation of the current situation of the Company and taking into account of the experience and past performance of Mr. Xiang, the Board is of the opinion that its is appropriate and in the best interests of the Company at the present stage for Mr. Xiang to hold both positions as the chairman and the chief executive officer of the Company as it helps to maintain the continuity of the policies and the stability of the operations of the Company.
Under the code provision A.4.1 of the Code, non-executive directors should be appointed for a specific term, subject to re-election. None of the existing non-executive Directors are appointed for a specific term. This constitutes a deviation from code provision A.4.1 of the Code. However, all Directors (including Independent Non-executive Directors) are subject to retirement by rotation in accordance with the Company’s Articles of Association. As such, the Board considers that sufficient measures have been taken to ensure that the Company’s corporate governance practices are no less exacting than those in the Code. Model Code on Securities Transactions by Directors The Company adopted the Model Code for Securities Transactions by Directors of Listed Issuer (“Model Code”) as set out in Appendix 10 of the Listing Rules as its own code of conduct regarding Directors’ securities transactions.
Having made specific enquiry of all Directors, the Directors of the Company have complied with the required standard set out in the Model Code during the six months ended 30 June 2012. Audit Committee The audit committee (the “Audit Committee”) was established by the Board since the listing of the Company’s shares on the Stock Exchange on 28 August 2002. The Audit Committee has its written terms of reference in compliance with the Code as set out in the Listing Rules. As at the date of this interim result announcement, the Audit Committee comprises three independent non-executive Directors, namely Mr. David Wang Xin, Mr. Zang Hong Liang and Mr. Lee Wing Hang. The principal duties of the Audit Committee include the review and supervision of the Company’s financial reporting system and internal control procedures and review of the Company’s financial information.
The Company’s interim result announcement for the six months ended 30 June 2012 has been reviewed by the Audit Committee. Sufficiency of Public Float The Company has maintained the prescribed public float under the Listing Rules, based on the information that is publicly available to the Company and within the knowledge of the Directors, throughout the six months ended 30 June 2012. China Innovation Investment Limited Xiang Xin Chairman and Chief Executive OfficerAs at the date of this announcement, the Executive Directors of the Company are Mr. Xiang Xin, Mr. Chan Cheong Yee, Mr. Li Zhou and Mr. Jook Chun Kui Raymond; the Non-executive Director is Mr. Ng Kwong Chue Paul; the Independent Non-executive Directors are Mr. David Wang Xin, Mr. Zang Hong Liang and Mr. Lee Wing Hang.
ALCOHOL AND DRUG TESTING PROCEDURES Alcohol and Drug Testing Procedures These alcohol and drug testing procedures shall apply where alcohol and drug testing of employees is warranted by the Total Energy Services Inc. ("Total Energy") Alcohol and Drug Policy. All testing of employees and contractors must be authorized by the appropriate management of Total Energy which i
December 2008 (Vol. 1, Issue 3, pages 45-46) ROLE OF THE ENDOCANNABINOID SYSTEM IN ATHEROSCLEROSIS By François Mach, MD, Fabrizio Montecucco, MD, Sabine Steffens, PhD Division of Cardiology, Foundation for Medical Researches, University Hospital, Geneva, Switzerland Introduction Atherosclerosis is an inflammatory disease that involves vascular and immune cell types. En